Table 2.

Proportion of children achieving zero inflammation or two-step reduction in anterior ocular inflammation after 3, 6, 9, and 12 months of infliximab therapy

	Baseline	3 months	6 months	9 months	12 months
No. patients (%) with zero ocular inflammation	1 (6%)	7 (44%)	9 (60%)	5 (45%)	9 (64%)
Comparison to baseline, P value	N/A	0.04	0.002	0.03	0.001
No. patients (%) with zero inflammation or two-step reduction in ocular inflammation	1 (6%)	12 (75%)	10 (67%)	9 (82%)	11 (79%)
Comparison to baseline, P value	N/A	0.0001	0.0006	0.0001	0.00000
Total no. patients for whom data available	16	16	15	11	14

No. = number, N/A = not applicable